Malcolm Salter's Insider Trades & SAST Disclosures
Malcolm Salter's most recent trade in C4 Therapeutics Inc was a trade of 32,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Note
This is a custom search result for pattern Malcolm Salter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 31.58 per share. | 04 Jan 2022 | 428 | 11,380 | - | 31.6 | 13,516 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 17 Dec 2021 | 755 | 10,952 | - | 30.3 | 22,839 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 40.11 per share. | 19 Nov 2021 | 755 | 11,707 | - | 40.1 | 30,283 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 44.94 per share. | 15 Oct 2021 | 755 | 12,462 | - | 44.9 | 33,930 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 44.99 per share. | 04 Oct 2021 | 300 | 13,217 | - | 45.0 | 13,497 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 49.89 per share. | 17 Sep 2021 | 755 | 12,917 | - | 49.9 | 37,667 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 40.73 per share. | 20 Aug 2021 | 755 | 13,672 | - | 40.7 | 30,751 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 37.37 per share. | 16 Jul 2021 | 755 | 14,427 | - | 37.4 | 28,214 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 02 Jul 2021 | 339 | 15,182 | - | 39.7 | 13,465 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 37.19 per share. | 18 Jun 2021 | 755 | 14,843 | - | 37.2 | 28,078 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Sale of securities on an exchange or to another person at price $ 37.12 per share. | 21 May 2021 | 755 | 15,598 | - | 37.1 | 28,026 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 37.51 per share. | 05 Apr 2021 | 359 | 16,353 | - | 37.5 | 13,466 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | 06 Oct 2020 | 100,000 | 0 | - | - | Series A Preferred Stock | ||
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | 06 Oct 2020 | 23,809 | 0 | - | - | Series B Preferred Stock | ||
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | 06 Oct 2020 | 11,856 | 11,856 | - | - | Common Stock | ||
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | 06 Oct 2020 | 2,823 | 14,679 | - | - | Common Stock | ||
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 06 Oct 2020 | 1,315 | 15,994 | - | 19 | 24,985 | Common Stock |
|
C4 Therapeutics Inc
52 week low |
Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 17,786 | 17,786 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges